Curevo Vaccine
A clinical-stage biotech company developing amezosvatein, a vaccine for shingles and chickenpox.
44 employees · est. 2017 · Bothell, United States
Valneva
Specialty vaccine company focused on prevention of infectious diseases with major unmet need, such as Lyme & chikungunya
637 employees · est. 2013 · Saint-herblain, France
Valneva is the older company (2017 vs 2013); Valneva is the larger of the two.
3 signals in the last 90 days
Side-by-Side Comparison
| Metric | Curevo Vaccine | Valneva |
|---|---|---|
| Founded | ||
| Founded | 2017 | 2013 older |
| Headquarters | ||
| Headquarters | Bothell, United States | Saint-herblain, France |
| Employees | ||
| Employees | 44 | 637 larger |
| Industry | ||
| Industry | Biopharma, Biotechnology, Health Care | Biotechnology, Health Care, Health and Wellness |
| Funding Stage | ||
| Funding Stage | Acquired | Grant |
| Total Funding | ||
| Total Funding | $196.00M | $720.10M |
| Funding Rounds | ||
| Funding Rounds | 4 | 15 |
| Services | ||
| Services | Development of next-generation non-mRNA vaccines, Clinical trials for vaccine efficacy and safety, Comparative studies with existing vaccines, Improving tolerability and accessibility of vaccines | Vaccine Research and Development, Manufacturing of Vaccines, Commercialization of Vaccines, Marketing and Distribution |
| Target Customers | ||
| Target Customers | Individuals susceptible to shingles and chickenpox, Immunocompromised patients, particularly children, Healthcare providers and institutions, Global health organizations and vaccine distributors | Healthcare Providers, Travelers, Health Organizations, Governments, Investors |
| Taxonomy | ||
| Taxonomy | Biotech, Vaccine Development, Clinical-Stage Biotech, Amezosvatein, Herpes Zoster Vaccine, Chickenpox Vaccine, Shingles Vaccine, Varicella Zoster Virus, Adjuvanted Subunit Vaccine, Immunology, Drug Development, Reactogenicity Improvement, Public Health, Infectious Disease, Clinical Trials | Specialty Vaccines, Infectious Disease Prevention, Prophylactic Vaccines, Vaccine Modalities, First-in-Class Vaccines, Only-in-Class Vaccines, Lyme Disease Vaccine, Chikungunya Vaccine, Travel Vaccines, Vaccine R&D, Vaccine Manufacturing, Clinical Development, Public Health Threats, Pfizer Partnership, Zika Virus Vaccine |
| Website | ||
| Website | curevovaccine.com | valneva.com |
About Curevo Vaccine
Curevo Vaccine, founded in 2017, is a clinical-stage biotech company based in the United States. Specializing in the development of vaccines for varicella and herpes zoster, the company is advancing its flagship product, Amezosvatein (CRV-101), a non-mRNA, adjuvanted subunit vaccine aimed at prevent...
About Valneva
Valneva, founded in 2013, is a France-based specialty vaccine company renowned for addressing infectious diseases with significant unmet needs. With a forward-thinking approach, the company prides itself on offering first-, best-, or only-in-class vaccine solutions. Their portfolio includes the worl...
We will tell you when either one moves
BounceWatch watches Curevo Vaccine and Valneva for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Curevo Vaccine and Valneva — by email.
Frequently Asked Questions
Compare Curevo Vaccine with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Curevo Vaccine on 11 Mar 2026, and Valneva on 11 Mar 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.